DOI:
10.1039/D4RA06436D
(Paper)
RSC Adv., 2024,
14, 33512-33523
An elegant approach for the synthesis of multisubstituted imidazole via FeCl3/SiO2 catalyzed activation of acetals: a photophysical study of an imidazole–carbazole hybrid†
Received
6th September 2024
, Accepted 8th October 2024
First published on 22nd October 2024
Abstract
A simple and solvent-free catalytic system was developed for the direct conversion of multisubstituted imidazoles through the reaction of acetals and benzils with ammonium acetate/amines as the source of nitrogen. The reaction occurred under mild and benign conditions using FeCl3/SiO2 as a heterogeneous catalyst without the requirement of any toxic organic solvents. The easy preparation and recyclability of the catalyst allows the reaction to be simple and highly efficient, resulting in very good yields of imidazoles. Novel imidazole–carbazole hybrid compounds were also synthesised by adopting the present methodology. Single crystal X-ray diffraction study indicated the presence of a CH⋯π supramolecular interaction that renders effective molecular packing in the solid state. The steady-state and spectro-dynamic behaviours of these hybrid molecules were investigated, and it was revealed that a solvent-dependent excimer-coupled ICT phenomenon guided excited state photophysics. Very unusual excimer lifetime was noticed in the solid state of this bis-heterocyclic compound owing to the stacking of molecules via CH⋯π interaction, as evident from the X-ray studies.
Introduction
The ideation for the synthesis of various unique heterocyclic compounds is of keen interest to organic and medicinal chemistry researchers because of their various applications in pharmaceutical chemistry, drug industry and many other areas of science.1,2 Imidazoles are a vital class of nitrogen-containing heterocycles that are present in numerous bioactive molecules and possess known biological and pharmacological activities,3–8 such as anti-obesity, anti-hypertension, anti-allergic, anti-inflammatory, anti-bacterial, anti-viral, anti-tumor, analgesic, anti-histaminic, anti-helminthic, anti-thyroid, and anti-ulcer activity. Furthermore, they have high versatile utility in other areas such as dyes for solar cells,9 agrochemicals,10 optical applications,11 functional materials,12 plant growth regulators, fungicides and herbicides.13 Some substituted imidazoles are selective antagonists of the glucagon receptors and inhibitors of IL-1 biosynthesis.14 Moreover, the imidazole nucleus constitutes the core unit of many natural products,15 such as histidine, histamine, biotin, and pilocarpine. Moreover, 2,4,5-triaryl imidazoles are popular building blocks for the construction of pharmaceutically interesting compounds, such as inhibitors of p38 MAP kinase16 and B-Raf kinase transforming growth factor b1,17 and are the core structural skeleton of several drugs, such as trifenagrel, eprosartan, and losartan.18 Substituted imidazoles also have important applications in the chemistry of functional materials, such as in functional polymers,19 ligands,20 photo-physical materials,21,22 ionic liquids,23 semiconductor devices,24 fluorescent probes,25 and N-heterocyclic carbenes.26 Hybrid molecules are chemical entities that have two or more structural domains with different functional roles and show dual activities in the biological function and modulation of functional materials. Hybrid molecules have the potential to minimize toxicity, widen the biological range, overcome drug cross-resistance, and improve efficacy as compared to the parent drugs. In recent years, covalently linked different functionalized heterocyclic units as the so-called organic–organic hybrid have emerged as a powerful tool for the modulation of their physical and electronic properties.27 Functional modification offers a direct and robust method for tuning their physicochemical properties in a controlled and modular manner. This is particularly important as the rational design of species with well-defined electronic properties remains a key target for both biological and photochemical applications.28 In this context, a imidazole–carbazole hybrid has attracted attention from chemists because of its bipolar D–π–A type transition for blue light-emitting diodes29 and electrochemical sensors.30 Consequently, the development of novel synthetic methods for the synthesis of diverse structured imidazoles has attracted sustained interest in organic synthesis. The tri- and tetra-substituted imidazoles can be synthesized by the reaction of a 1,2-diketone/α-hydroxy ketone with an aldehyde and ammonium acetate and/or primary amines under acidic condition,31–35 microwave reactor,36 and using different heterogeneous metal catalysts (Scheme 1, route A).37–40 Other approaches like the reaction of α-haloketone with a substituted amidine10,11,41 (Scheme 1, route B) or the cyclocondensation of N-alkyl-α-acetamido ketone/alcohol with ammonium acetate in HOAc under reflux42 (Scheme 1, route C), or by the condensation of imines and acyl chloride over a palladium catalyst (Scheme 1, route D)43 have been reported for the synthesis of multisubstituted imidazoles. Recently, the visible light-induced photo-cyclization of amines to imidazoles via C–C/C–N bond coupling, followed by dehydrogenation reaction over Mo-doped ZnIn2S4 as a heterogeneous photocatalyst was also reported (Scheme 1, route E).44 Although there are various ways to synthesize imidazoles (Scheme 1), some of the catalysts possess objectionable drawbacks from the view point of environment and green chemistry. Thus, the development of a new and simple strategy is still desirable for the direct construction of poly-substituted imidazoles with more economic viability and sustainability.
|
| Scheme 1 Different routes towards the synthesis of substituted imidazoles. | |
Nowadays, solid-supported reagents using polystyrene-based resin and silica gel as the scavenger are gaining increasing attention due to several advantages associated with them. However, silica gel has been widely accepted since it is less expensive and structurally rigid with high mechanical and thermal stability. Silica gel also does not swell in any organic solvents. Thus, it can be used in various reaction media. Most importantly, silica gel has a large surface area (typically 200–800 m2 g−1), which allows for a high density of functional groups to be immobilized on its surface.45 Due to the Lewis acid character of iron(III) chloride, it is extensively used in organic synthesis as a catalyst/activator since it is also inexpensive and readily available. However, this reagent cannot be recycled after its use, which ultimately creates pollution problems. By considering the aforementioned features of the supported reagents as a heterogeneous catalyst, we have successfully utilized silica-supported ferric chloride (FeCl3/SiO2) as an activator for various functional groups and in various occasions.46,47 It was reported that the acetal group can be activated by ferric chloride48 or other transition metal catalysts49 for the synthesis of heterocycles and other purposes under mild condition. Based on the above fact, we were curious to explore whether such activation could be applied to the synthesis of multisubstituted imidazoles using acetal as latent aldehydes under the FeCl3/SiO2 catalytic condition. Thus, we report herein our findings on to the synthesis of 2,4,5-tri and 1,2,4,5-tetra substituted imidazoles in the presence of a silica-supported FeCl3/SiO2 catalyst under solvent-free condition using different protected acetals as the source of the C-2 carbon (Scheme 2). Due to the structural uniqueness of one of the synthesized multisubstituted imidazole–carbazole hybrid compounds, we also demonstrated its solid state packing pattern and photo-physical behaviour in this communication.
|
| Scheme 2 General reaction scheme for the synthesis of substituted imidazoles. | |
Results and discussion
Based on our previous experience,32 we have decided to begin with Amberlite IR 120 H+ as the catalyst to optimize the best reaction condition to achieve maximum yield of the product. So, we begin by reacting benzil (1a; 1 mmol) with benzaldehyde dimethyl acetal (2a; 1.1 mmol), ammonium acetate (5.0 mmol), and Amberlite IR 120 H+ (30 mg) in methanol at room temperature. No reaction was detected on a TLC plate (Table 1, entry 1). However, upon refluxing the mixture for 3 h in methanol or ethanol, 2,4,5-triphenyl imidazole was obtained in 65% yield from the reaction mixture after purification (Table 1, entries 2 and 3). Surprisingly, when the reaction was carried using dry methanol or THF, or without catalyst or solvent, by keeping the ratios of the reactants the same, no product was detected (entries 4–6). The reaction is also unsatisfactory for the catalyst Amberlyst 15 under identical conditions (entry 8). Having in mind the Lewis acidic nature of FeCl3, we then turned our attention toward its use as an activator for acetals. Accordingly, we have employed a catalytic amount of anhydrous ferric chloride (20 mg mmol−1) in dichloromethane at room temperature, but such attempt resulted in a mixture of products (Table 1, entry 9), along with unreacted benzil. Refluxing the reaction mixture in methanol/ethanol in the presence of silica-supported ferric chloride (20 mg, 2 mol% of FeCl3) resulted in an incomplete conversion to products (Table 1, entries 10 and 11). However, one of the products was identified as 2,4,5-triphenyl imidazole on a TLC plate by the comparison of the standard sample. Then, we were curious to see the outcome of the reaction under solvent-free conditions. Accordingly, a mixture of 1a (1 mmol) with 2a (1.1 mmol) and ammonium acetate (5 mmol) and FeCl3/SiO2 (20 mg) was heated without the use of any solvent for 1 h at 100 °C. Under this condition, a clean conversion occurred and 93% yield of 2,4,5-triphenyl imidazole (3a) was isolated after work-up (Table 1, entry 12). Decreasing the temperature to 80 °C again showed incompatibility of the process (Table 1, entry 13). From this promising result, extending the reaction time to 4.0 h or increasing the amount of supported catalyst only had a slight influence on the yield (Table 1, entries 14 and 15). To gain further insight into the reaction system, control experiments were conducted in the presence of silica-gel only. However, no product was detected (Table 1, entry 16). Decreasing the amount of the catalyst (10 mg), while keeping the others constant, resulted in a decreased yield of the tri-substituted imidazole (Table 1, entry 17). An exhaustive literature search revealed that different synthetic procedures employed variable amounts of ammonium acetate, depending on the reaction conditions, to produce the desired product in maximum yield. Thus, to complete our optimization study, we also employed variable amounts of ammonium acetate. However, considerably lower yields were obtained when 1 and 2 equivalents were used, and the use of 10 equivalents does not affect the yield of 2,4,5-tri phenyl imidazole (Table 1, entries 18–20). We also found that the catalyst can be recycled through at least five consecutive cycles without the loss of catalytic potency (93% initial, 92%, 92%, 90% and 89%) of FeCl3/SiO2 (Table 1, entry 21).
Table 1 Optimization of the reaction conditions for the formation of 2,4,5-triphenylimidazole from benzil and benzaldehyde dimethylacetal via a domino multicomponent reaction
|
Entry |
Solvent |
Catalyst |
NH4OAc |
Temp. (°C) |
Time (h) |
Yield (%) |
1 |
MeOH |
Amberlite IR 120 H+ (30 mg) |
5.0 eq. |
rt |
3.0 |
NR |
2 |
MeOH |
Amberlite IR 120 H+ (30 mg) |
5.0 eq. |
Reflux |
3.0 |
65 |
3 |
EtOH |
Amberlite IR 120 H+ (30 mg) |
5.0 eq. |
Reflux |
180 |
65 |
4 |
MeOH (dry) |
Amberlite IR 120 H+ (30 mg) |
5.0 eq. |
Reflux |
3.0 |
Trace |
5 |
THF (dry) |
Amberlite IR 120 H+ (30 mg) |
5.0 eq. |
rt |
3.0 |
NR |
6 |
MeOH |
None |
5.0 eq. |
Reflux |
3.0 |
NR |
7 |
No |
Amberlite IR 120 H+ (30 mg) |
5.0 eq. |
80 °C |
3.0 |
Trace |
8 |
MeOH |
Amberlyst 15 (30 mg) |
5.0 eq. |
Reflux |
1.0 |
57 |
9 |
CH2Cl2 |
FeCl3 (20 mg) |
5.0 eq. |
Reflux |
1.0 |
Mixture |
10 |
MeOH |
FeCl3/SiO2 (20 mg) |
5.0 eq. |
Reflux |
1.0 |
Mixture |
11 |
EtOH |
FeCl3/SiO2 (20 mg) |
5.0 eq. |
Reflux |
3.0 |
Mixture |
12 |
No |
FeCl3/SiO2 (20 mg) |
5.0 eq. |
100 °C |
1.0 |
93 (ref. 32) |
13 |
No |
FeCl3/SiO2 (20 mg) |
5.0 eq. |
80 °C |
1.0 |
Mixture |
14 |
No |
FeCl3/SiO2 (20 mg) |
5.0 eq. |
100 °C |
4.0 |
94 |
15 |
No |
FeCl3/SiO2 (50 mg) |
5.0 eq. |
100 °C |
1.0 |
94 |
16 |
No |
Silica-gel (230–400 mesh) |
5.0 eq. |
100 °C |
1.0 |
Mixture |
17 |
No |
FeCl3/SiO2 (10 mg) |
5.0 eq. |
100 °C |
4.0 |
85 |
18 |
No |
FeCl3/SiO2 (20 mg) |
1.0 eq. |
100 °C |
1.0 |
Mixture |
19 |
No |
FeCl3/SiO2 (20 mg) |
2.0 eq. |
100 °C |
1.0 |
65 |
20 |
No |
FeCl3/SiO2 (20 mg) |
10.0 eq. |
100 °C |
1.0 |
93 |
21 |
No |
FeCl3/SiO2 (20 mg) |
5.0 eq. |
100 °C |
1.0 |
93, 92, 92, 90, 89 |
We then turned our attention to the expansion of the sources of nitrogen by replacing ammonium acetate with other ammonium salts like ammonium chloride, ammonium formate, ammonium nitrate and ammonium sulphate. However, our study revealed that NH4OAc is best, and the only effective source of nitrogen in the present method of imidazole synthesis (results not shown). Therefore, the conditions described in Table 1, entry 12 using benzil/benzaldehyde dimethylacetal/ammonium acetate in a molar ratio of 1:1.1:5 were found to be optimal, allowing for maximum conversion into the desired product 3a. With the optimal reaction condition in hand, the scope of the devised system was evaluated by varying the substituted benzils and acetals (Table 2). Acetals of aromatic aldehydes substituted with either electron-donating (2b) or electron-withdrawing (2c) functional groups in the para position reacted smoothly with 1a and 5 eq. of ammonium acetate to provide the corresponding 2,4,5-triarylimidazoles 3b–c in excellent yields (90% and 92%, respectively) (Table 3, entries 1 and 2). The presence of the –NO2 group in acetal makes the process a little slower. 4,4′-Dimethoxy benzil (1b) also reacts with both the benzaldehyde dimethyl acetal or 4-methoxy benzaldehyde dimethyl acetal under identical conditions to produce the corresponding triaryl imidazoles 3d–e in excellent yields. To expand the scope of our methodology, cyclic-1,2-dione, e.g., phenanthroquinone (1c), was evaluated for the present strategy, and also furnished the expected imidazoles 3f–g in high yields. Next, reactions of benzaldehyde dimethyl acetals with butane 2,3-dione or cyclohexa-1,2-diones were investigated. Unfortunately, such attempts were not compatible with this transformation, even though various reaction conditions were tried. To further evaluate the scope of the developed system, cyclic acetal (2d) was used in the same reaction with benzil, and an almost comparable yield of triaryl imidazole 3a was observed. We have also extended our study with the ketal generated from acetone (2e) under standardized condition (Table 1, entry 12), and the expected 2,2-dimethyl-4,5-diphenyl-2H-imidazole (3h) was isolated in 80% yield after 1 h.
Table 2 Scope of the SiO2/FeCl3-catalysed synthesis of trisubstituted imidazoles using NH4OAc as the source of nitrogen
Entry |
1,2-Dicarbonyl |
Acetal |
Product |
Time (h) |
Yield (%) |
1 |
|
|
|
60 |
90 (ref. 32) |
2 |
|
|
|
120 |
92 (ref. 32) |
3 |
|
|
|
60 |
90 |
4 |
|
|
|
90 |
87 |
5 |
|
|
|
90 |
90 (ref. 50) |
6 |
|
|
|
120 |
88 (ref. 51) |
7 |
|
|
|
60 |
NR |
8 |
|
|
|
60 |
NR |
9 |
|
|
|
60 |
90 (ref. 32) |
10 |
|
|
|
60 |
80 |
Table 3 Solvent-free synthesis of 1,2,4,5-tetrasubstituted imidazoles through a MCR of diketone, protected aldehydes, NH4OAc, and amine using the FeCl3/SiO2 catalyst
Entry |
1,2-Dicarbonyl |
Acetal and amine |
Product |
Time (min) |
Yield (%) |
1 |
|
|
|
60 |
91 (ref. 32) |
2 |
|
|
|
60 |
93 (ref. 32) |
3 |
|
|
|
90 |
89 (ref. 52) |
4 |
|
|
|
90 |
85 (ref. 53) |
5 |
|
|
|
90 |
82 (ref. 54) |
6 |
|
|
|
120 |
86 |
7 |
|
|
|
140 |
82 |
Based on the optimized reaction conditions, we have also devised the protocol for the synthesis of 1,2,4,5-tetrasubstituted imidazoles (5) using ammonium acetate, along with primary amines (4) as the source of the second nitrogen. Thus, we performed the synthesis via four-component, one-pot condensation of benzils (1), acetal (2), NH4OAc and primary amines (4) in the presence of FeCl3/SiO2 under the standardized condition (Table 1, entry 12). Both aromatic and aliphatic primary amines furnished tetra-substituted imidazoles in excellent yield (82–93%). Benzylamine provided better yield (5b, 93%) than aniline (5a, 91%) because of its better nucleophilicity. In the case of p-toluidine and p-methoxy aniline, the reaction proceeded efficiently under solvent-free conditions, and 1,2,4,5-tetrasubstituted imidazoles 5c–d were produced in high yields. 4-Methoxy benzaldehyde dimethyl acetal also participated in the reaction with benzil, aniline and ammonium acetate to yield tetrasubstituted imidazole 5e in 82% yield. However, phenanthroquinone reacted with benzaldehyde dimethyl acetal, aniline and ammonium acetate to yield the phenanthrene-fused imidazole derivative 5f in 86% yield. Finally, we have achieved a very interesting synthesis of imidazole–carbazole hybrid compounds via the present four-component protocol using benzil, benzaldehyde dimethylacetal, ammonium acetate and 9-ethyl-3-amino carbazole under the standardized condition, and the hybrid compound 5g was formed in 82% yield after 2.5 h. The structural uniqueness of 5g containing two heterocyclic units could lead to novel photo-physical and optoelectronic properties, apart from the expected intramolecular charge transfer (ICT) commonly shown in carbazole and imidazole moieties separately. The single crystal X-ray analysis provides valuable information on the supramolecular interactions, which could in turn dictate their optoelectronic properties. Thus, we were also interested to see the solid-state structure of 5g by X-ray diffraction studies, as the compound is found to be a highly crystalline solid. For this, single crystals were grown in a methanol–water solvent system to obtain suitable ones for analysis. Fig. 1(A) shows the ORTEP diagram of 5g (CCDC deposition number 2361185) at 60% probability of the thermal ellipsoids, whereas Fig. 1(B) shows the packing of two molecules of 5g in a unit cell. As 5g comprises considerable π electron density, non-classical supramolecular interactions were also expected to be present via non-classical hydrogen bonding interactions. Fig. 1(C) and (D) illustrate the supramolecular architecture attained in 5g. In Fig. 1(C), the presence of non-classical CH⋯π hydrogen bonding interactions (dH–X⋯A ≥ 2.0 Å) could be visualized. Fig. 1(D) shows how the cumulative result of all such interactions leads to knitting a beautiful zig-zag assembly that extends in three dimensions.
|
| Fig. 1 (A) ORTEP diagram of 5g. (B) Unit cell packing of 5g. (C) Non-classical hydrogen bonding interaction between three units of 5g. (D) Supramolecular architecture attained by the C–H⋯π interactions among individual units of 5g. | |
Photo-physical study of imidazole–carbazole hybrid 5g
The design of molecular frameworks to purposefully tune intriguing photo-physical phenomena, such as excited state proton transfer (ESIPT), excited state intramolecular charge transfer (ESICT), excimer formation, among others, has attracted the attention of chemists for a long time, owing to their multifarious utilities in the fields of sensing, bio-imaging and organic electronics.55–57 In this connection, the spectroscopic properties of the new compound 5g (Table 3, entry 7) were investigated. The rationale behind choosing the same was the unique unison of carbazole, as well as imidazole units, both being very well-studied fluorophore units individually. However, the structural uniqueness of the conjugation of the two units could lead to novel spectroscopic properties apart from the expected intramolecular charge transfer (ICT) commonly shown in carbazole and imidazole moieties separately. To our delight, 5g showed rare excimer-based emission, a phenomenon observed predominantly in molecular entities like naphthalene, pyrene and perylene. The excimer emission band appeared as a broad, red-shifted band emitting at λem ≥ 400 nm (λex 300 nm) depending on the solvent in the steady state emission profile, whereas the time-resolved emission decays consisted of abnormally high lifetime values (6.0–12.0 ns), accompanied with a growth component (τgrowth = 0.20–0.70 ns) in polar solvents, thereby providing solid support in favor of excimer emission. In addition, in chloroform, evidence of a feeble ESICT could be obtained from the combined steady-state and time-resolved experiments. However, the solid-state emission was guided exclusively by monomer and excimer emission, without involvement of an ESICT (τexcimer = 17.0 ns). To our knowledge, this is the first report demonstrating a carbazole-substituted imidazole-enabled excimer emission, along with weak ESICT, depending on the solvent polarity and viscosity. Prior to the current report, excimer formation was observed in some triphenylamine- and pyrrole-conjugated carbazole derivatives, albeit the spectro-dynamic properties were not explored.58,59 In the current report, the detailed spectro-dynamic studies and steady-state experiments make it an improvement over the existing reports. The simple design yet elegant spectroscopic features of 5g shall act as a guideline for unravelling the excited state photo-physical phenomena in the tailor-made carbazole–imidazole hybrid fluorophores. All steady-state and time-resolved measurements in solution were performed by using 15 μM solutions of 5g (purity > 99.99%; HPLC, ESI) prepared in various solvents of differing polarity, proticity, and viscosity (viz., chloroform, tetrahydrofuran, dimethylformamide, methanol and water of pH 7.0). For measurements in aqueous solution, the stock solution of 5g in THF was diluted in water (pH 7.0) to get a final concentration of 15 μM. For solids, a morsel of powdered 5g was smeared on a 1 cm × 2 cm Whatman 40 filter paper strip using a spatula, and the filter paper coated with 5g was used for spectroscopic measurements. The radiation areas of the emission spectrophotometer, as well as the nano-LED, were much lower than the area of 5g smeared on the filter paper, ensuring no scattering from the filter paper.
Steady-state spectral features in solution and solid phase
To begin with, the steady-state spectra of 5g were recorded in solution ([5g] = 15 μM), as well as in the solid phase (powdered form) (Fig. 2). The spectral features in the solution phase shall be discussed first, followed by that of the solid phase. Table 4 lists the important spectral data of 5g in various solvents. From Fig. 2(A), it could be found that 5g shows a structured absorption band centred at ∼300 nm, along with a very weak band at ∼360 nm. The high-energy band could be assigned to the π → π* transition, which is in line with reported carbazole based molecules.60,61 The low-energy band can be assigned to the n → π* transition, owing to the extremely low extinction coefficient (ε300 nm:ε400 nm ∼ 17:1 in chloroform to 25:1 in MeOH) of the latter.62 It should be noted that the contribution of the lower energy band in terms of absorbance is particularly high in chloroform. Hence, this could be due to some weak charge transfer operative in 5g, which is somewhat dampened in solvents of higher polarity (THF, DMF and MeOH) due to the unequal stabilization of the ground and excited states. In water (pH 7.0), the absorption band lost its vibrational nature to some extent, along with a broad tail spanning from 400 nm to ∼550 nm. This could be rationalized by considering the poor solubility of 5g in water, possibly inducing the formation of aggregates in solution, which is reported to afford a Mie scattering-induced broad absorption tail.63
|
| Fig. 2 (A) Steady-state absorption (dashed lines) and emission (solid lines) spectra of 5g in various solvents, as indicated in the figure. The concentration was 15 μM and the excitation wavelength was 300 nm. (B) Steady-state absorption (dashed line) and emission (solid line) spectra of 5g in the solid state. The excitation wavelength was 300 nm. | |
Table 4 Important steady state spectral data of 5g
Solvent |
Abs. (nm) |
Em (nm)/(ex 290 nm) |
Stokes' shift (cm−1) |
CHCl3 |
290, 300, 360 |
350, 420 |
5911, 10673 |
THF |
290, 300, 350 |
350, 400 |
5911, 9483 |
DMF |
290, 300, 350 |
350, 400 |
5911, 9483 |
MeOH |
290, 300, 350 |
350, 400 |
5911, 9483 |
Water |
290, 300 |
350, 420 |
5911, 10673 |
Upon exciting 5g at 300 nm (the most intense absorption band), some interesting emission spectral features were observed. The common feature in all solvents was the appearance of a structured band from 350–370 nm, typical of carbazole derivatives,64 and a broad tail from 400–450 nm. One striking difference in chloroform was the presence of a very broad tail from 400 nm, and spanning through the spectral region of the experiment. The presence of a homogeneous electronic ground state was ensured by the following: (i) excitation-independent emission spectrum, and (ii) overlap of the excitation spectrum with the absorption spectrum (ESI, Fig. S1†).
From Fig. 2(B), it could be seen that the excitation spectrum of 5g is broad with a significantly red-shifted excitation maximum (∼350 nm). The solid-state emission spectrum is independent of the excitation wavelength, with a structured emission band with an emission maximum at 450 nm. The red shift in the absorption and emission spectra in the solid-state could be due to stabilization of the electronic states caused by non-classical interactions, as evidenced from the crystal structure analysis [Fig. 1(D)]. Structured bands observed in the solid-state form appear, contradicting the generally observed disappearance of vibrational bands in the solid-state emission spectra of organic fluorophores.65,66 However, this could also be the result of various types of aggregates (J, H, etc.), resulting in such an undulated nature of the emission spectrum or more than one emitting species in the excited state, which could not be clarified from the steady-state emission spectrum. Thus, although the steady-state emission spectra in the solution and solid phase could provide useful information about the morphological behaviour of the emission spectra of 5g in various states of aggregation, no concrete idea about the identity and number of emitting species could be obtained. Hence, the emission lifetime analysis was required to understand the photobehaviour of 5g.
Time-resolved emission lifetime in solution and the solid phase
The emission lifetime of 5g was recorded in various solvents and at various emission wavelengths (340 nm – 490 nm). Table 5 lists the emission lifetime parameters of 5g in various solvents and in the solid state. The complete decays at various observed wavelengths are presented in the ESI (Fig. S2 and S3†), whereas the emission decays at 340 nm and 430 nm in various solvents, as well as the full emission decays at various observed wavelengths in the solid-state form are presented in Fig. 3(A)–(C), respectively. We first present a discussion on the solution phase, followed by the emission behaviour in the solid phase. In solution, upon excitation at 296 nm, the obtained emission decays [Fig. 3(A) and (B)] showed multi-exponential decay behaviour (Table 5). The common feature in all of the solvents was the presence of a sub-nanosecond to a few nanoseconds component (τ1 = 0.8–1.2 ns), and a long-lived component (τ2 = 8.0–12.0 ns). τ1 had greater contribution in the blue region of observation, whereas τ2 had greater contribution in the red region of observation (Table 5). In chloroform, methanol and water, an additional shorter component (τ0 = 0.20–0.70 ns) was required to provide a good fit to the emission decays (Table 5). In addition, in methanol and water, τ0 decayed in the blue and rose in the red. The abnormally high value of the τ2 component hints at an excimer-like emission, keeping in mind the structure-less red-shifted 400 nm emission band encountered in solution (vide supra), whereas the τ1 component could be associated with emission from locally excited 5g molecules. The rising nature of the τ0 component directly proves a common channel between the monomer and the excimer species, and was strong evidence in favour of excimer emission, as observed for compounds showing excimer emission like naphthalene, pyrene and perylene.67–69 It should be noted that the excimer lifetime varies from one solvent to another, particularly in THF and DMF. The excimer emission lifetime changes with the polarity of the solvent in the case of molecules, where a n → π* transition hampers the true value of the excimer lifetime.70 The additional growth component in methanol and water could be explained by considering how the monomer-to-excimer formation is slowed down in protic solvents.71 Finally, the additional lifetime component in chloroform needed to be treated separately, as it was not a rising one. There was a considerably high contribution at the red region of observation in chloroform, apart from the fact that it had a significantly high lifetime. The fact that the time component does not show any rising nature outright negates the possibility of it being the time constant for the monomer → excimer photoconversion. In addition, the very high contribution to the excited state population (35–78%, Table 5) signifies some other excited-state photo-event operative in chloroform, apart from excimer formation. At this juncture, the steady state spectral feature of 5g in chloroform was revisited [Fig. 2(A)], which consisted of a considerably broad and red shifted tail with much higher Stokes' shift compared to that of the excimer band (Table 5). These two factors hinted at some excited state charge transfer event (ICT) in 5g, which is the operative along with the excimer emission in chloroform, leading to the multi-exponential decay behaviour as observed.
Table 5 Excited state lifetime parameters of 5g in various solvents. [α1,s] denotes the contribution to the excited state population. The error in estimation of the lifetimes is around 10%. Negative α denotes a growth component
State |
λobs (nm) |
τ1 (ns) |
α1 (%) |
τ2 (ns) |
α2 (%) |
τ3 (ns) |
α3 (%) |
CHCl3 |
340 |
— |
— |
2.3 |
95 |
12.0 |
5 |
370 |
— |
— |
90 |
10 |
400 |
— |
— |
80 |
20 |
430 |
0.70 |
35 |
45 |
20 |
460 |
0.70 |
80 |
10 |
10 |
490 |
0.70 |
78 |
12 |
10 |
THF |
340 |
— |
— |
0.8 |
75 |
8.0 |
25 |
370 |
— |
55 |
45 |
400 |
— |
47 |
53 |
430 |
— |
40 |
60 |
DMF |
340 |
— |
— |
1.2 |
75 |
9.0 |
25 |
370 |
— |
70 |
30 |
400 |
— |
60 |
40 |
430 |
— |
59 |
41 |
MeOH |
340 |
0.70 |
35 |
1.5 |
25 |
9.0 |
40 |
370 |
25 |
40 |
35 |
400 |
(−)100 |
80 |
120 |
430 |
(−)100 |
85 |
115 |
Water |
340 |
0.33 |
75 |
1.0 |
15 |
10.0 |
10 |
370 |
55 |
30 |
15 |
400 |
(−)100 |
80 |
120 |
430 |
(−)100 |
70 |
130 |
Powder |
350 |
0.20 |
70 |
1.2 |
25 |
17.0 |
5 |
380 |
65 |
35 |
10 |
410 |
60 |
25 |
15 |
440 |
55 |
30 |
15 |
470 |
(−)100 |
80 |
120 |
500 |
(−)100 |
70 |
130 |
|
| Fig. 3 Lifetime emission decays of 5g in various solvents [(A and B) (15 μM)] and solid states (C). The excitation and monitoring wavelengths are provided in the insets. | |
In the solid state, the behaviour was like that observed in methanol and water, along with an abnormally high excimer lifetime of 17.0 ns [Fig. 3(C) and Table 5]. The excimer lifetime is particularly high due to the already existing packing and stacking in the solid state, as evidenced in the crystal structure discussion [Fig. 1(A) and (B)], which is reported to enhance the excimer lifetime.72 To explain photobehaviour in a concise manner, a photophysical scheme has been constructed and shown in Scheme 3.
|
| Scheme 3 Schematic of photophysical events in 5g (not to scale). (The abbreviation of the terms are as follows: ISC = intersystem crossing, ICT = intramolecular charge transfer, E = excimer, and M = monomer). | |
In light of the literature reports48,49 and our previous work73 on account of the activation of acetal, a plausible mechanism of the present study is depicted in Fig. 4. It was known that the acetal group can be activated by ferric chloride or other transition metal catalysts for the synthesis of heterocycles and other functional materials under mild condition via C–O bond cleavage.48,49 Thus, we believe that iron of FeCl3/SiO2 coordinates with both oxygens of acetal and facilitated the formation of the intermediate oxonium ion (B) after expulsion of alkoxide (R′O−) from (A). Then, ammonia/amine acts as a nucleophile to attack the highly reactive oxonium ion (B) to produce intermediate (C), which upon subsequent release of second R′O− by N–triggered elimination to produce imine (D). This reactive intermediate imine (D) invites a second molecule of ammonia/amine to participate in the nucleophilic addition reaction to afford aminal (E). This aminal then reacts with silica–ferric chloride-activated dione again to produce another imine (F), followed by ring closing to regenerate the catalyst and intermediate imidazolium cation (G). The release of the proton, following aromatization, yields imidazole 3 or 5 depending upon the stoichiometry of the ammonium acetate or amine used. However, the involvement of the initial formation of any carbonyl compound via hydrolytic cleavage of acetal by the catalysis of FeCl3 (ref. 74) is precluded, as evident from the NMR experiments. A solution of 2c (10 mg) in DMSO-d6 (0.6 mL) was taken in an NMR tube, then 1H NMR spectra were recorded in the presence of FeCl3/SiO2 at ambient temperature after 30 min of shaking. No signal of the aldehydic functional group due to hydrolytic cleavage of the diethyl acetal group in 2c was traced.
|
| Fig. 4 Probable mechanism of the formation of 3 and 5. | |
Conclusions
In conclusion, we have developed a benign catalytic system for the direct conversion to multisubstituted imidazoles by the reaction of acetals and benzils with ammonium acetate/amines as the source of nitrogen. The reaction occurred under mild conditions using FeCl3/SiO2 as the heterogeneous catalyst without the requirement of any toxic organic solvents. Novel imidazole–carbazole hybrid compounds were also synthesised by adopting the present methodology. Single crystal X-ray diffraction studies indicated the presence of CH⋯π supramolecular interaction, which renders efficient molecular packing in the solid state. The steady state and spectro-dynamic investigation of one of the synthesized molecules having an imidazole–carbazole unit was investigated, and it was revealed that a solvent-dependent excimer-coupled ICT phenomenon guided the excited state photophysics. In the solid state, the compound showed an abnormally high excimer lifetime of about 17.0 ns. The investigation is ongoing in our group to suitably modify 5g to drive the emission and absorption to the green-red region for subsequent studies on the biological imaging potential of the same class of compounds prepared in the current report.
Experimental section
General
1H and 13C NMR spectra were measured on a Bruker Ascend 400 spectrophotometer at ambient temperature using 400 MHz for 1H and 100 MHz for 13C. Chemical shifts were reported in parts per million from the tetramethyl silane and coupling constants were reported in hertz. Proton multiplicities were represented as s (singlet), d (doublet), dd (double doublet), t (triplet), q (quartet), and m (multiplet). FTIR spectra were recorded on a Bruker Alpha II FTIR spectrometer on neat or KBr pellets. Mass spectra (HRMS) were obtained from Orbitrap Exploris 120 (Thermo Scientific) using 70 eV in the positive ion mode. The single-crystal X-ray diffraction (XRD) data were collected on a Bruker D8 Venture system with a microfocus optics using Cu Kα radiation. The data were analysed and processed with Bruker Apex III software suite 61 incorporated with multiple tools, such as cell_now and RLATT for the determination of the unit cell, SAINT-plus for data reduction, and SADABS for absorption correction. The structure solutions were performed with SHELXT, and the full-matrix least-squares refinements were performed with the SHELXL suite of programs incorporated in Olex 2.6. The steady-state absorption spectra were collected on a Shimadzu® UV-1900 absorption spectrophotometer. The steady-state emission spectra were collected in a Shimadzu RF-6000 emission spectrophotometer. Emission lifetime experiments were performed using a HORIBA® Jobin-Yvon TCSPC setup using a nano-LED light source of 296 nm (IRF ∼ 0.6 ns). Emission lifetime data were deconvoluted and fitted using the DAS-6 software by HORIBA, which allows for individual and batch fits.
Materials
All reagents were purchased either from Sigma-Aldrich Chemical Co., USA, Acros Chemical Company, or SRL India, and were used as received unless otherwise specified. Commercially supplied petroleum ether (60–80 °C) and ethyl acetate were distilled before use. Column chromatography was performed on silica gel (60–120 mesh, 0.12–0.25 mm). Analytical thin-layer chromatography (TLC) was performed on 0.25 mm extra-hard silica gel plates with a UV254 fluorescent indicator. The silica-supported ferric chloride reagent was prepared and stored as per the procedure previously described by us.47
Synthesis
General procedure for the synthesis of tri and tetra-substituted imidazoles. A small glass vial was charged with the catalyst (FeCl3/SiO2) (20 mg, 2 mol% of FeCl3), benzil (1.0 mmol), acetal (1.1 mmol), ammonium acetate (5.0 mmol) [for trisubstituted imidazoles] or ammonium acetate (2.5 mmol) and amine (2.5 mmol) [for tetra-substituted imidazoles], and then the mixture was heated at 100 °C until the full consumption of benzil (TLC). After completion of the reaction, the reaction mixture was diluted with EtOAc (5 mL), filtered, and the catalyst was washed with ethyl acetate. The combined filtrate was evaporated under vacuum. The desired product was isolated either by crystallization or by column chromatography using ethyl acetate–hexane (1:3 to 3:1).
Characterization data of the selected tri-substituted imidazoles.
4,5-Bis(4-methoxyphenyl)-2-phenyl-1H-imidazole (3d). Yield: 90%, white solid, mp 170–172 °C [lit. 75 yellow oil]; IR (KBr) νmax 2944, 2830, 1501, 1241, 1174 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.86 (d, J = 6.8 Hz, 2H), 7.42–7.35 (m, 7H), 6.84 (d, J = 8.0 Hz, 4H), 3.81 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 158.8, 145.6, 132.3, 130.0, 129.1, 128.7, 128.5, 125.4, 125.3, 113.9, 55.2; HRMS calcd for (C23H20N2O2 + H+) 357.1603, found: 357.1591 (M + H+).
2,2-Dimethyl-4,5-diphenyl-2H-imidazole (3h). Yield: 85%, white solid, mp 58–60 °C [lit. 76 brown oil]; IR (KBr) νmax 3053, 2981, 2929, 1610, 1492, 1445, 1215, 801 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.54–7.52 (m, 4H), 7.46 (t, J = 7.6 Hz, 2H), 7.37 (t, J = 7.6 Hz, 4H), 1.68 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 164.2, 132.7, 130.2, 128.9, 128.3, 101.6, 24.2; HRMS calcd for (C17H16N2 + H+) 249.1392, found: 249.1434 (M + H+).
Characterization data for the new tetra-substituted imidazoles (5).
1,2-Diphenyl-1H-phenanthro[9,10-d]imidazole (5f). Yield: 86%, white solid, mp 192–194 °C; IR (KBr) νmax 1693, 1459, 1385, 1136, 919, 692 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.92 (d, J = 8.0 Hz, 1H), 8.80–8.72 (m, 2H), 7.79–7.54 (m, 10H), 7.33–7.20 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 151.0, 138.7, 137.4, 130.5, 130.1, 129.8, 129.5, 129.3, 129.1, 128.8, 128.3, 128.2, 128.1, 127.3, 127.2, 126.3, 125.6, 124.9, 124.1, 123.1, 123.1, 122.8, 120.9; HRMS calcd for (C27H18N2 + H+) 371.1548, found: 371.1538 (M + H+).
9-Ethyl-3-(2,4,5-triphenyl-1H-imidazol-1-yl)-9H-carbazole (5g). Yield: 82%, white solid, mp 146–148 °C; IR (KBr) νmax 3051, 2972, 1593, 1476, 1223, 1136, 1080, 923, 688 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.96 (d, J = 8.0 Hz, 1H), 7.83 (s, 1H), 7.67 (d, J = 8.0 Hz, 2H), 7.53–7.50 (m, 3H), 7.44 (d, J = 8.4 Hz, 1H), 7.32–7.18 (m, 14H), 4.35 (q, J = 7.2 Hz, 2H), 1.46 (t, J = 7.6 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 147.3, 140.5, 139.1, 138.0, 134.7, 131.6, 131.1, 130.9, 130.8, 128.8, 128.6, 128.2, 128.1, 128.0, 127.7, 127.4, 126.5, 126.4, 125.9, 122.9, 122.4, 120.7, 120.4, 119.2, 108.8, 108.5, 37.7, 13.8; HRMS calcd for (C35H27N3 + H+) 490.2283, found: 490.2283 (M + H+); HPLC (acetonitrile), Rt = 14.188 min, 100%.
Data availability
The data supporting this article are available as part of the supplementary information (ESI†). Crystallographic data for 5g has been deposited at the Cambridge Crystallographic Data Centre (CCDC) under the deposition number 2361185 and can be obtained from https://www.ccdc.cam.ac.uk and https://www.fiz-karlsruhe.de.
Author contributions
S. M. designed the work. B. D. performed all experiments. A. B. contributed to the photophysical and lifetime measurement studies. B. P. and R. N. performed XRD studies and the processing of the X-ray data. S. M. and B. D. analyzed the spectral data, and wrote the manuscript with input from A. B. All authors reviewed and approved the final version of the manuscript.
Conflicts of interest
There are no conflicts to declare. The authors also declare that no funds, grants, or other support were received during the preparation of this manuscript.
Acknowledgements
We are grateful to the Department of Science and Technology, Govt. of India, for providing the 400 MHz NMR facility under DST-FIST (No. SR/FST/CSI-263/2015) and CIC, Tripura University for the instrumental facility. B. D. sincerely acknowledges Tripura University for providing the Non-NET fellowship.
Notes and references
- B.-F. Ruan, Q.-L. Guo, Q.-S. Li, L.-Z. Li, G. S. Deora and B.-G. Zhou, Curr. Top. Med. Chem., 2022, 22, 578–599 CrossRef CAS PubMed.
- M. Yar, M. Bajda, S. Shahzad, N. Ullah, M. A. Gilani, M. Ashraf, A. Rauf and A. Shaukat, Bioorg. Chem., 2015, 58, 65–71 CrossRef CAS PubMed.
- A. Siwach and P. K. Verma, BMC Chem., 2021, 15, 12 CrossRef CAS PubMed.
- D. I. Ma Gee, M. Bahramnejad and M. Dabiri, Tetrahedron Lett., 2013, 54, 2591–2594 CrossRef CAS.
- A. Magyar and Z. Hell, Synlett, 2019, 30, 89–93 CrossRef CAS.
- A. Reyes-Arellano, O. Gómez-García and J. Torres-Jaramillo, Med. Chem., 2016, 6, 561–570 Search PubMed.
- A. Verma, S. Joshi and D. Singh, J. Chem., 2013, 2013, 329412 CrossRef.
- D. A. Shabalin and J. E. Camp, Org. Biomol. Chem., 2020, 18, 3950–3964 RSC.
- I. B. A. Ghani, M. Khalid, M. I. Hussain, M. M. Hussain, R. Ashraf and J. Wang, Mater. Sci. Semicond. Process., 2022, 148, 106788 CrossRef.
- M. Kumar, D. Kumar and V. Raj, Current Synthetic and Systems Biology, 2017, 5, 1000135 Search PubMed.
- M. Y. Berezin, J. Kao and S. Achilefua, Chemistry, 2009, 15, 3560–3566 CrossRef CAS PubMed.
- S. Zaman, K. Mitsuru and A. D. Abell, Org. Lett., 2005, 7, 609–611 CrossRef CAS PubMed.
- P. Koch, C. Bäuerlein, H. Jank and S. Laufer, J. Med. Chem., 2008, 51, 5630–5640 CrossRef CAS PubMed.
- E. M. Perchellet, J. P. Perchellet and P. W. Baures, J. Med. Chem., 2005, 48, 5955–5965 CrossRef CAS PubMed.
- G. Haberhauer and F. Rominger, Eur. J. Org Chem., 2003, 3209–3218 CrossRef CAS.
- A. Negi, J. M. Alex, S. M. Amrutkar, A. T. Baviskar, G. Joshi, S. Singh, U. C. Banerjee and R. Kumar, Bioorg. Med. Chem., 2015, 23, 5654–5661 CrossRef CAS PubMed.
- T. F. Gallagher, S. M. Fier-Thompson, R. S. Garigipati, M. E. Sorenson, J. M. Smietana, D. Lee, P. E. Bender, J. C. Lee, J. T. Laydon, D. E. Griswold, M. C. Chabot-Fletcher, J. J. Breton and J. L. Adams, Bioorg. Med. Chem. Lett., 1995, 5, 1171–1176 CrossRef CAS.
- C. Leister, Y. Wang, Z. Zhao and C. W. Lindsley, Org. Lett., 2004, 6, 1453–1456 CrossRef PubMed.
- T. Yamamoto, T. Uemura, A. Tanimoto and S. Sasaki, Macromolecules, 2003, 36, 1047–1053 CrossRef CAS.
- H. Konishi, T. Ueda, T. Muto and K. Manabe, Org. Lett., 2012, 14, 4722–4725 CrossRef CAS PubMed.
- V. G. Sree, C. Bathula, H.-K. Youi, H.-S. Kim, J. I. Sohn and H. Im, J. Mol. Liq., 2021, 338, 116708 CrossRef.
- Y. Dong, J. Qian, Y. Liu, N. Zhu, B. Xu, C. L. Ho, W. Tian and W. Y. Wong, New J. Chem., 2019, 43, 1844–1850 RSC.
- B. A. Omotowa and J. M. Shreeve, Organometallics, 2004, 23, 783–791 CrossRef CAS.
- N. T. Zhang, C. C. Zeng, C. M. Lam, R. K. Gbur and R. D. Little, J. Org. Chem., 2013, 78, 2104–2110 CrossRef CAS PubMed.
- S. R. Nayak, S. Patel and S. Vaidyanathan, New J. Chem., 2023, 47, 3524–3534 RSC.
- P. Bellotti, M. Koy, M. N. Hopkinson and F. Glorius, Nat. Rev. Chem, 2021, 5, 711–725 CrossRef CAS PubMed.
- N. A. Kukhta and M. R. Bryce, Mater. Horiz., 2021, 8, 33–55 RSC.
- J. Gierschner, J. Shi, B. Milián-Medina, D. Roca-Sanjuán, S. Varghese and S. Park, Adv. Opt. Mater., 2021, 9, 2002251 CrossRef CAS.
- Y. Tan, Z. Zhao, L. Shang, Y. Liu, C. Wei, J. Li, H. Wei, Z. Liu, Z. Bian and C. Huang, J. Mater. Chem. C, 2017, 5, 11901–11909 RSC.
- X. Wang, J. Lin, H. Li, C. Wang and X. Wang, RSC Adv., 2022, 12, 4437–4445 RSC.
- D. Kumar, D. N. Kommi, N. Bollineni, A. R. Patel and A. K. Chakraborti, Green Chem., 2012, 14, 2038–2049 RSC.
- M. Chakraborty, B. Deb, B. Dey, S. A. Hussain, D. K. Maiti and S. Majumdar, ChemistrySelect, 2017, 2, 241–245 CrossRef CAS.
- M. Antolini, A. Bozzoli, C. Ghiron, G. Kennedy, T. Rossi and A. Ursini, Bioorg. Med. Chem. Lett., 1999, 9, 1023–1028 CrossRef CAS PubMed.
- C. Mukhopadhyay and P. K. Tapaswi, Green Chem. Lett. Rev., 2012, 5, 109–120 CrossRef CAS.
- K. F. Shelke, S. B. Sapkal, G. K. Kakade, B. B. Shingate and M. S. Shingare, Green Chem. Lett. Rev., 2010, 3, 27–32 CrossRef CAS.
- X. L. Yu, Y. H. Fan, X. N. Zheng, J. F. Gao, L. G. Zhuang, Y. L. Yu, J. H. Xi and D. W. Zhang, Molecules, 2023, 28, 4845 CrossRef CAS PubMed.
- H. Naeimi and D. Aghaseyedkarimi, New J. Chem., 2015, 39, 9415–9421 RSC.
- M. Nejatianfar, B. Akhlaghinia and R. Jahanshahi, Appl. Organomet. Chem., 2017, 32, e4095 CrossRef.
- Z. Zarnegar and J. Safari, New J. Chem., 2014, 38, 4555–4565 RSC.
- J. Mullaivendhan, I. Akbar, M. K. Gatasheh, A. A. Hatamleh, A. Ahamed, M. H. S. Abuthakir and R. Gurusamy, BMC Chem., 2023, 17, 155–170 CrossRef CAS PubMed.
- D. S. Weinstein, W. Liu, K. Ngu, C. Langevine, D. W. Combs, S. Zhuang, C. Chen, C. S. Madsen, T. W. Harper and J. A. Robl, Bioorg. Med. Chem. Lett., 2007, 17, 5115–5120 CrossRef CAS PubMed.
- C. F. Claiborne, N. J. Liverton and K. T. Nguyen, Tetrahedron Lett., 1998, 39, 8939–8942 CrossRef CAS.
- A. R. Siamaki and B. A. Arndtsen, J. Am. Chem. Soc., 2006, 128, 6050–6051 CrossRef CAS PubMed.
- M. Wang, L. Li, J. Lu, N. Luo, X. Zhang and F. Wang, Green Chem., 2017, 19, 5172–5177 RSC.
- M. B. Gawande, R. Hosseinpour and R. Luque, Curr. Org. Synth., 2014, 11, 526–544 CrossRef CAS.
- S. Majumdar, A. Chakraborty, S. Bhattacharjee, S. Debnath and D. K. Maiti, Tetrahedron Lett., 2016, 57, 4595–4598 CrossRef CAS.
- B. Deb, S. Debnath, A. Chakraborty and S. Majumdar, RSC Adv., 2021, 11, 30827–30839 RSC.
- T. Xu, Q. Yang, D. Li, J. Dong, Z. Yu and Y. Li, Chem.–Eur. J., 2010, 16, 9264–9272 CrossRef CAS PubMed.
- S. Ghosh, S. Khamarui, K. S. Gayen and D. K. Maiti, Sci. Rep., 2013, 3, 2987 CrossRef PubMed.
- N. L. Higuera, D. Peña-Solórzano and C. Ochoa-Puentes, Synlett, 2019, 30, 225–229 CrossRef CAS.
- S. Damavandi, Heterocycl. Commun., 2011, 17, 79–81 CAS.
- S. S. Dipake, V. D. Ingale, S. A. Korde, M. K. Lande, A. S. Rajbhoj and S. T. Gaikwad, RSC Adv., 2022, 12, 4358–4369 RSC.
- M. Waheed, N. Ahmed, M. A. Alsharif, M. I. Alahmdi and S. Mukhtar, ChemistrySelect, 2017, 2, 7946–7950 CrossRef CAS.
- Y. Ran, M. Li and Z.-Z. Zhang, Molecules, 2015, 20, 20286–20296 CrossRef CAS PubMed.
- A. C. Sedgwick, L. Wu, H. H. Han, S. D. Bull, X. P. He, T. D. James, J. L. Sessler, B. Z. Tang, H. Tian and J. Yoon, Chem. Soc. Rev., 2018, 47(55), 8842–8880 RSC.
- S. Thazhathethil, T. Muramatsu, N. Tamaoki, C. Weder and Y. Sagara, Angew. Chem., Int. Ed., 2022, 61, e202209225 CrossRef CAS PubMed.
- Y. Chen, Molecules, 2022, 27, 8628 CrossRef CAS PubMed.
- S. A. Bagnich, S. Athanasopoulos, A. Rudnick, P. Schroegel, I. Bauer, N. C. Greenham, P. Strohriegl and A. Köhler, J. Phys. Chem. C, 2015, 119, 2380–2387 CrossRef CAS.
- C. Zhao, T. Schwartz, B. Stöger, F. J. White, J. Chen, D. Ma, J. Fröhlich and P. Kautny, J. Mater. Chem. C, 2018, 6, 9914–9924 RSC.
- C. Chen, K. C. Chong, Y. Pan, G. Qi, S. Xu and B. Liu, ACS Mater. Lett., 2021, 3, 1081–1087 CrossRef CAS.
- P. Naik, K. S. Keremane, M. R. Elmorsy, A. El-Shafei and A. V. Adhikari, Electrochem. Sci. Adv., 2022, 2, e2100061 CrossRef CAS.
- D. C. Harris and M. D. Bertolucci, Symmetry and Spectroscopy: An Introduction to Vibrational and Electronic Spectroscopy, Dover Publications, New York, 3rd edn, 1989 Search PubMed.
- G. S. He, W. C. Law, L. Liu, X. Zhang and P. N. Prasad, Appl. Phys. Lett., 2012, 101, 011110 CrossRef.
- N. Guven and P. Camurlu, J. Electrochem. Soc., 2015, 162, H867–H876 CrossRef CAS.
- T. Schillmöller, P. N. Ruth, R. Herbst-Irmer and D. Stalke, Chem.–Eur. J., 2020, 26, 17390–17398 CrossRef PubMed.
- J. L. Song, C. Lei and J. G. Mao, Inorg. Chem., 2004, 43, 5630–5634 CrossRef CAS PubMed.
- K. Uchida, M. Tanaka and M. Tomura, J. Lumin., 1979, 20, 409–414 CrossRef CAS.
- D. Ray Chawdhury, S. Narayanan, T. Agrawal and P. B. Bisht, J. Lumin., 2023, 263, 120084 CrossRef.
- H. Yoo, J. Yang, A. Yousef, M. R. Wasielewski and D. Kim, J. Am. Chem. Soc., 2010, 132, 3939–3944 CrossRef CAS PubMed.
- E. Sebastian, J. Sunny and M. Hariharan, Chem. Sci., 2022, 13, 10824–10835 RSC.
- G. Xie, Y. Sueishi and S. Yamamoto, J. Fluoresc., 2005, 15, 475–483 CrossRef CAS PubMed.
- X. Shan, W. Chi, H. Jiang, Z. Luo, C. Qian, H. Wu and Y. Zhao, Angew. Chem., 2023, 62(72), e202215652 CAS.
- S. Majumdar, M. Chakraborty, D. K. Maiti, S. Chowdhury and J. Hossain, RSC Adv., 2014, 4, 16497–16502 RSC.
- S. E. Sen, S. L. Roach, J. K. Boggs, G. J. Ewing and J. Magrath, J. Org. Chem., 1997, 62(19), 6684–6686 CrossRef CAS.
- L.-M. Recnik, M. A. El Hameid, M. Haider, M. Schnürch and M. D. Mihovilovic, Synthesis, 2013, 45, 1387–1405 CrossRef CAS.
- X.-L. Wu and L. Dong, Org. Lett., 2018, 20, 6990–6993 CrossRef CAS PubMed.
|
This journal is © The Royal Society of Chemistry 2024 |
Click here to see how this site uses Cookies. View our privacy policy here.